Senator Bernie Sanders is taking aim at the exorbitant prices of weight-loss drugs Ozempic and Wegovy, manufactured by a Danish pharmaceutical company. These drugs, which have become incredibly popular in the United States, are priced at a rate that is ten times higher than in other countries. Wegovy and Ozempic have become household names in America, often associated with celebrities like Oprah Winfrey and touted as life-changing by medical professionals. However, the high demand for these drugs, which are used not only by individuals with diabetes but also by those struggling with obesity, has highlighted a major issue in the American healthcare system - the cost of medication. Senator Sanders plans to question the CEO of the pharmaceutical company responsible for these drugs about the pricing disparity between the US and other countries. The inflated prices of Wegovy and Ozempic are seen as unacceptable, especially considering the significant impact they can have on individuals' health and well-being. The debate over the cost of these weight-loss drugs reflects a larger issue within the healthcare industry in the US, where medication prices often put a strain on individuals and families. Sanders' efforts to address this issue are part of a broader push for more affordable and accessible healthcare for all Americans.